Glucose-lowering therapy delayed for newly diagnosed T2DM patients
(HealthDay)—For adults newly diagnosed with type 2 diabetes mellitus (T2DM), delays to first-line therapy are longest for older patients, those who are Black or of other ethnicities, and those with multimorbidity, according ...